Pregnancy Outcome in Women with Sickle Cell Hemoglobinopathy and Normal Hemoglobin – A Case–Control Study

  • Neha Harne NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra India
  • Anuja Bhalerao NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra India
  • Krutika Bhalerao Bhalerao Nursing Home, Nagpur, Maharashtra India
Keywords: Pregnancy outcome, Sickle cell disease, Sickle cell hemoglobinopathy, Sickle cell trait


Introduction: Pregnancy in sickle cell disease (SCD) is associated with an increased risk of maternal and fetal morbidity and mortality.
Objective: The objective of this study was to study the maternal and perinatal outcome of pregnancy in women with SCD/trait.
Methods: This is a comparative study. Study group (subjects) consisted of 128 pregnant women with SCD/sickle cell trait who were attending the antenatal clinic or were admitted in obstetric wards and followed up until the 7th day after delivery. The control group consisted of 256 age and gravidity matched pregnant women who did not have SCD/trait recruited from the same hospital.
Results: Statistically significant complications during pregnancy included anemia, crisis, and preeclampsia. Incidence of preterm deliveries, cesarean section, adverse fetal outcome in terms of stillbirths intrauterine deaths early neonatal deaths, and low birth weight was not significantly higher in the study group than in the control group.
Conclusion: Incidence of preeclampsia (P = 0.0001) and congestive cardiac failure (P = 0.0001) was significantly high among the women with SCD.

Author Biographies

Neha Harne, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra India

Post Graduate, Department of Obstetrics and Gynecology, 

Anuja Bhalerao, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra India

Professor, Department of Obstetrics and Gynecology, 

Krutika Bhalerao, Bhalerao Nursing Home, Nagpur, Maharashtra India

Junior Consultant, 


1. Misra RC, Padhi K. Hemoglobinopathy and erythrocytic glucose 6
phosphate dehydrogenase deficiency in pregnant women of North Western
Orissa. J Obstet Gynecol India 1988;38:678-82.
2. UNDP. Government of India Annual Report. UNDP; 2001-2002.
3. Dare FO, Makinde OO, Faasuba OB. The obstetric performance of sickle
cell disease patients and homozygous hemoglobin C disease patients in Ile-
Ife, Nigeria. Int J Gynaecol Obstet 1992;37:163-8.
4. El-Shafei AM, Dhaliwal JK, Sandhu AK. Pregnancy in sickle cell disease in
Bahrain. Br J Obstet Gynaecol 1992;99:101-4.
5. Chhabra S, Gupta S, Aher K. Perinatal outcome in women with sickle cell
disease/trait. IJCP 1994;5:25.
6. Leborgne-Samuel Y, Janky E, Venditelli F, Salin J, Daijardin JB,
Couchy B, et al. Sickle cell anemia and pregnancy: Review of 68 cases in
Guadeloupe. J Gynecol Obstet Biol Reprod (Paris) 2000;29:86-93.
7. Odum CU, Anorlu RI, Dim SI, Oyekan TO. Pregnancy outcome in Hb SS
cell disease in Lagos, Nigeria. West Afr J Med 2002;21:19-23.
8. Idrisa A, Omigbodun AO, Adeleye JA. Pregnancy in hemoglobin sickle cell
patients at the university college hospital, Ibadan. Int J Gynaecol Obstet
9. Deshmukh MB. Fusey SS, Yerawar N. Sickle cell anemia complicating
pregnancy. J Obstet Gynecol India 1995;45-4.
10. Howard RJ, Tuck SM, Pearson TC. Pregnancy in sickle cell disease in the UK:
Results of a multicentre survey of the effect of prophylactic blood transfusion
on maternal and fetal outcome. Br J Obstet Gynaecol 1995;102:947-51.
11. Sun PM, Wilburn W, Raynor BD, Jamieson D. Sickle cell disease in
pregnancy: Twenty years of experience at grady memorial hospital, Atlanta,
Georgia. Am J Obstet Gynecol 2001;184:1127-30.
12. Royal College of Obstetricians and Gynaecologists. Management of Sickle
Cell Disease in Pregnancy. RCOG Green Top Guideline 61. London:
RCOG; 2011.